Registration
SUN PHARMACEUTICAL INDUSTRIES, INC. for SUN PHARMACEUTICAL INDUSTRIES, INC.
Income
—
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
232 tariffs, drug pricing
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEREMY ALLEN New | — |
Medicare/Medicaid MMM
232 tariffs, drug pricing
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEREMY ALLEN New | — |
Trade (domestic/foreign) TRD
232 tariffs, drug pricing
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEREMY ALLEN New | — |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| SHANGHVI FINANCE PRIVATE LIMITED | India | India | 40.3% | — |
| SUN PHARMA (NETHERLANDS) B.V. | Netherlands | Netherlands | 96.4% | — |
| SUN PHARMA HOLDINGS UK LTD. | United Kingdom | United Kingdom | 96.4% | — |
| SUN PHARMACEUTICAL INDUSTRIES LIMITED | India | India | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.